Spending on prescription drugs that are covered under the medical benefit increased by 65% between 2014 and 2018 for commercial insurers and 40% for Medicare, according to Magellan Rx Management’s annual Medical Pharmacy Trend Report. A Magellan executive says the release of expensive new therapies — especially cancer drugs — is a main driver of price growth.
To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.